Northwestern University will execute the study titled ‘Retrospective, real-world evaluation of clinical and healthcare resource utilization outcomes associated with Astagraf XL in a large US transplant center.’ This includes the development of a study synopsis, study protocol, statistical analysis plan (SAP), and final study report based on collaboration discussions between Northwestern University and Astellas. Deliverables include: study synopsis and protocol, SAP, and study report.
|Effective start/end date||1/20/16 → 5/31/17|
- Astellas Pharma Global Development, Inc. (Agmt 1/20/16)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.